Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Spectrix Therapeutics

2016 FOUNDED
PRIVATE STATUS
Angel LATEST DEAL TYPE
$249K LATEST DEAL AMOUNT
Description

Provider of drug delivery services. The company is engaged in drug delivery services and develops new drug products.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Primary Office
  • 2535 East Southlake Boulevard
  • Suite 200
  • Southlake, TX 76092
  • United States

+1 (817) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Spectrix Therapeutics’s full profile, request a free trial.

Spectrix Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 03-Jun-2016 $249K 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Spectrix Therapeutics Executive Team (1)

Name Title Board
Seat
Contact
Info
Mark Tengler Co-Founder & Chief Executive Officer